Eko Health, Inc.

Oakland, California

Classification

Private

About

About

Eko Health is a healthcare technology company specializing in advanced digital stethoscopes and AI-powered diagnostic software. The company aims to revolutionize cardiovascular care by integrating cutting-edge technology with traditional stethoscopes, enabling clinicians to detect heart and lung diseases more effectively and efficiently. Product/Service Line Breakdown: 1. CORE 500 Digital Stethoscope: An FDA-cleared stethoscope featuring heart disease detection AI, 3-lead ECG, and advanced audio capabilities for precise diagnostics. 2. DUO ECG + Digital Stethoscope: Combines ECG and digital stethoscope functionalities to provide comprehensive cardiac assessment tools in a single device. 3. Eko App: AI-supported analysis software that works with Eko stethoscopes to enhance the detection and monitoring of cardiovascular conditions through real-time data analysis and visualization. 4. Telehealth Solutions: Integrated telehealth platform that enables remote patient monitoring and virtual consultations, enhancing accessibility to high-quality cardiac care. 5. Eko Enterprise Platform: Provides health systems and large practices with a scalable solution for managing cardiovascular care, including analytics, reporting, and integration with existing electronic health records (EHR).

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

Keywords

Keywords

Classified

Private